EUROIMMUN Medizinische Labordiagnostika AG

The company was founded in 1987 from the University of Lübeck (Germany). In 2018, the US American company PerkinElmer, Inc. became the sole shareholder of EUROIMMUN. In 2023, the two PerkinElmer business divisions “Life Sciences” and “Diagnostics” were converted into the new company Revvity, Inc., which also includes EUROIMMUN.

Revvity, Inc. is a science-based solutions company that leverages innovation in life sciences and diagnostics to help improve lives everywhere. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and from diagnosis to cure.

Revvity’s Headquarters are located in Waltham, Massachusetts. With revenues of more than $2.7 billion in 2023 and over 11,000 employees worldwide, Revvity serves customers in pharmaceutical and biotech companies, diagnostic labs, academia, and governments in more than 190 countries. It is included in the S&P 500 Index.

Among the initial pioneering achievements of EUROIMMUN was the development of BIOCHIPs in 1983. Today, the company uses virtually fully automated BIOCHIP fragmentation and production machines which are designed and produced in-house and are in use worldwide.

Furthermore, the company commands a broad technology base, which it has drawn on to stimulate and promote fundamental new developments in medical laboratory diagnostics. Examples are the molecular biological synthesis of designer antigens, the computer-based immunofluorescence microscopy (CAIFM) and the development of multiparameter microarrays for the identification of gene polymorphisms and pathogens.

High professional competence and continuing education are essential in the use and distribution of EUROIMMUN products. The EUROIMMUN Academy receives more than 1000 customers from over 100 countries for scientific trainings every year. Moreover, there are training laboratories in several countries. Furthermore, the accredited Institute for Quality Assessment affiliated to EUROIMMUN offers quality assessment schemes to help to maintain a high-quality standard in external laboratories.

The Institute for Experimental Immunology, another EUROIMMUN institution, is dedicated to basic research. The institute maintains cooperations with universities, clinics and renowned research institutions from all over the world, which have also resulted in numerous diploma and doctoral theses. EUROIMMUN is ISO-certified (EN ISO 13485:2016, ISO 9001:2015, MDSAP) and has successfully passed various international inspections (FDA, ANVISA, KGMP, UMCC, etc.).

The Clinical Immunological Laboratory of Prof. Dr. med Winfried Stöcker, cooperating with EUROIMMUN, offers a special service by providing fast and differential diagnostics to customers and clarifying difficult result constellations in several hundreds of patient samples per day.

EUROIMMUN meets its needs for qualified personnel not only through its presence at recruitment or trade fairs and via advertisements, but also through its own training and dual degree programs. In addition to vocational school, the trainees undergo a comprehensive practical and theoretical program and receive intensive support in their everyday work life. At present, the company has more than 3500 employees, of which 101 are apprentices and students. 1897 employees have an academic qualification and 245 a doctoral degree. The percentage of female employees is around 60 percent.

The atmosphere in the company is productive and characterised by openness and respect. All employees receive company pension benefits and bonus payments for outstanding performance. They also have the opportunity for regular further training. The excellent company restaurant offers a variety of freshly prepared meals every day. Children are well looked after in the company’s own crèche and kindergarten while their parents are working nearby.